Company: FEAV
Filing Date: 2025-02-03
Form Type: DEF 14A
Source: 0000950170-25-012391
Chunk: 382

Company: 5E Advanced Materials, Inc.
Filing Date: 2025-02-03
Form: DEF 14A
Chunk 382
---
 offer.

(vi)If, on or after the Amendment No. 2 Effective Date and on or prior to December 31, 2024, the Issuer or any of its Subsidiaries issues or otherwise sells any shares of Common Stock, or any Equity-Linked Securities, in each case at an Effective Price per share of Common Stock that is less than the Conversion Price in effect for the Amendment No. 2 Notes or

<div align='center'>50</div>

the Amendment No. 3 Notes, as applicable, (before giving effect to the adjustment required by this Section 2.8(d)(vi)) as of the date of the issuance or sale of such shares or Equity-Linked Securities (such an issuance or sale, a “Degressive Issuance”), then, effective as of the Close of Business on such date, the Conversion Rate applicable to the Amendment No. 2 Notes or the Amendment No. 3 Notes, respectively, will be increased to an amount equal to (x) one thousand dollars ($1,000)divided by(y) the Weighted Average Issuance Price. For these purposes, the “Weighted Average Issuance Price” will be equal to:

where:

CP= such Conversion Price;

OS= the sum of (1) number of shares of Common Stock and (2) the number of shares into which the Notes could be converted if fully converted, in each case outstanding immediately before such Degressive Issuance;

EP= the Effective Price per share of Common Stock in such Degressive Issuance; and

X= the sum, without duplication, of (x) the total number of shares of Common Stock issued or sold in such Degressive Issuance; and (y) the maximum number of shares of Common Stock underlying such Equity-Linked Securities issued or sold in such Degressive Issuance;

provided,however, that (1) the Conversion Rate will not be adjusted pursuant to this Section2.8(d)(vi)solely as a result of an Exempt Issuance or as a result of any transaction in respect of which an adjustment is made pursuant toSection 2.8(d)(i),(ii),(iii),(iv)and/or(v); (2) the issuance of shares of Common Stock pursuant to any such Equity-Linked Securities will not constitute an additional issuance or sale of shares of Common Stock for purposes of thisSection 2.8(d)(vi)(it being understood, for the avoidance of doubt, that